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ABSTRACT 
Asthma has a major public health impact in the United States and worldwide. Climbing asthma 
rates have triggered a search for environmental factors that could be contributing to the 
prevalence or severity of asthma. Among substantial changes over the past several decades has 
been a dramatic increase in folate intake, caused by widespread foodstuff fortification as well as 
maternal vitamin supplementation. Findings in a murine model suggest that folate 
supplementation affects offspring asthma risk. Cross-sectional studies in humans yield weak 
evidence of an inverse association between folate and asthma risk, in which lower folate is 
associated with greater odds of asthma. Birth cohort studies, on the other hand, provide weak 
evidence of a positive association between maternal folate supplementation and offspring asthma 
risk. Folate is a methyl donor that could theoretically alter asthma risk by contributing to the 
methylation of disease-modifying genes. Nevertheless, given the weak evidence for folate in 
modifying asthma risk, as well as the proven public health importance of folate in the prevention 
of neural tube defects, there is insufficient evidence to change current recommendations 
regarding folate supplementation during pregnancy. More clarity from well-designed, large 
observational studies, with careful measurement of folate status and asthma phenotypes, is 
necessary. 
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1.0 INTRODUCTION 
In the United States (U.S.), the prevalence of asthma increased from 7.3% in 2001 to 8.4% in 
2010, when approximately 25.7 million persons were estimated to have asthma
1
. Among other 
factors, altered eating habits (including nutrients such as vitamin D, vitamin E, or zinc) have 
been proposed as causes of increased childhood asthma
2-4
. A maternal diet enhanced with folate, 
for example, can theoretically lead to increased or reduced risk of offspring asthma by producing 
changes in DNA methylation
5
. Folate is a methyl donor that could alter asthma risk by 
contributing to methylation of disease genes in relevant tissues. Findings in murine models 
support this hypothesis
6
 and encourage the exploration of an association between folate status 
and asthma or other allergic disease (i.e., atopy) in humans. In this review, I survey both 
gestational studies (evaluating the effect of maternal folate on offspring) and proband studies 
(evaluating the effect of folate status in children and adults). These studies represent the effect of 
folate status along a single temporal continuum, from fetal through adult exposures. 
Studies of maternal folate status and the development of asthma or atopy have varied 
results. In some studies, increased maternal folate has been shown to increase risk of offspring 
wheezing
7-9
, while in other studies increased maternal folate has been shown to decrease 
offspring wheezing risk
10
 or have no effect whatsoever
11-13
. Nevertheless, a majority of 
gestational exposure studies find that increased maternal folate is associated with elevated risk of 
offspring wheezing, asthma, or other atopy, and there are plausible epigenetic mechanisms for 
these offspring risks
14,15
.  
On the other hand, folate status can have effects in patients at risk for asthma (i.e., 
proband effects) that differ from the gestational effects of maternal folate supplementation. 
While gestational exposure is identified as a possible risk factor for asthma, folate intake may in 
 2 
fact protect children and adults from the development of asthma. Such an inverse relationship 
between folate status and markers of atopy is noted in several cross-sectional studies
16-18
. 
Proband studies of the MTHFR C677T polymorphism, which can be interpreted as a marker of 
low folate status
19
, do not show uniform evidence of this inverse relationship
12,19-21
, however. 
Folate supplementation is proven to offer substantial protection against neural tube 
defects (NTD) in newborns
22
. Prior to sounding a warning regarding a link between folate and 
asthma, the quality and quantity of evidence must be considered. The public health challenge 
posed by folate involves balancing the known benefits regarding NTD, and unknown risks 
regarding asthma. Periconceptional folic acid administration is an ongoing public health issue, 
given that vulnerable groups (e.g., young and poorly educated) are less likely to adhere to 
standards regarding vitamin supplementation
23
. In a review of international studies, 
preconceptional folic acid use is noted to vary from 0.9% to 50%
24
. Given this poor adherence to 
guidelines at baseline, the premature announcement of heretofore unreported disease risk could 
be an irresponsible deterrent. 
This review is a thorough examination of the existing evidence for association between 
folate status and asthma or atopy. Section 2 is a discussion of the primary animal model of 
gestational folate exposure, and section 3 is a review of human studies. Section 4 covers the 
complex issue of folate measurement as it impacts comparability of these studies. Section 5 deals 
with gene-by-environment interactions in folate metabolism, with a focus on MTHFR 
polymorphisms. In Section 6, I explore possible mechanisms for folate effects on asthma and 
other forms of atopy. Finally, Section 7 summarizes the public health significance of existing 
literature on folate and asthma. 
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1.1 FOLATE METABOLISM 
 
Figure 1. Folate metabolism 
 
Folic acid is a synthetic form of folate used in fortification and supplementation. Absorption of 
dietary folates occurs in the proximal small intestine. Folic acid is among the monoglutamate 
forms of folate that can be easily absorbed. Polyglutamates, including natural food folates, need 
to be hydrolyzed prior to absorption, and bioavailability of dietary folates is estimated as 
approximately half that of folic acid
25
. Precise Dietary Folate Equivalents (DFEs) that account 
for differences in bioequivalence between folic acid and dietary folates are difficult to 
establish
26
. Folate absorption is saturable, and as intake increases, unreduced folic acid can 
appear in the circulation
27
. 
Folate is essential to synthesize purines and pyramidines, as well as to metabolize amino 
acids, but is also needed for the formation of S-adenosylmethionine (SAM). SAM has a role in 
 4 
the methylation pathways of phospholipids, RNA, and DNA
28
. Folate metabolism also generates 
essential and nonessential amino acids, including serine, glycine, cysteine, and methionine. 
The tetrahydrofolate (THF) molecule is a methyl acceptor that is converted to methylene-
THF. The subsequent conversion of this metabolite to 5-methyl-THF is catalyzed by methylene 
tetrahydrofolate reductase (MTHFR) in the rate-limiting step of folate metabolism. During this 
process, a methyl group is transferred to homocysteine, resulting in the production of 
methionine
29
 that regenerates SAM (summarized in Figure 1). 
A C to T substitution at position 677 is a common missense mutation in the MTHFR 
gene. This mutated gene product has reduced enzymatic function
30
. Due to the impairment, the 
MTHFR C677T polymorphism is identified as a genetic marker of decreased serum folate
19
. 
Moreover, via this interaction with folate status, the MTHFR C677T polymorphism also can 
affect DNA methylation status
31
. 
 
2.0 ANIMAL MODELS 
Hollingsworth et al. report the primary animal study assessing folate status and the development 
of respiratory disease
6
. Using a murine model, they supplement the maternal diet with methyl 
donors, including folic acid. Offspring of these mice (the F1 generation) are more likely to have 
evidence of airway hyperreactivity, lung lavage eosinophilia and IL-13, as well as elevated 
serum IgE. Some of these traits are subsequently transmitted to the F2 generation. 
The investigators also seek to distinguish between gestational effects (on the F1 
generation), and the proband effects of childhood and adult methyl donor exposure. Probands 
exposed to methyl donors only during lactation or adulthood do not develop significant 
 5 
differences in markers of allergic airway disease. Therefore, the investigators note that methyl 
donor exposure appears to have pro-atopic effects during gestation only
6
. 
To identify whether epigenetic changes account for these findings, DNA methylation in 
lung tissue in F1 mice that undergo high-methyl-donor gestation is compared with methylation in 
F1 mice that undergo low-methyl-donor gestation. Significant differences in methylation are 
observed, with 82 loci showing significant differences and representing potential candidate genes 
in the development of allergic airway disease
6
. 
The hypothesized effect of this DNA methylation, decreased transcription in splenocytes 
of mice gestated under a high-methyl-donor diet, is reversible. Application of a demethylating 
agent in vitro produces a significant increase in Runx3 mRNA. Runx3 is a gene that negatively 
regulates allergic airway disease.
6
 This animal study provides some of the most compelling data 
suggesting a connection between folate and asthma, as mediated by methylation. 
 
3.0 EPIDEMIOLOGY OF FOLATE AND ASTHMA OR ATOPY 
Murine model findings prompted epidemiologic study of the relationship between folate status 
and asthma or atopy. These studies (summarized in Tables 1 and 2) examine many temporal 
relationships between folate status and asthma or atopy, have variable sample sizes, and have 
varying classification of wheezing and folate status. Selection bias could affect many of these 
studies
32
 since they either involve a subset of participants from a larger recruitment or represent a 
significant loss of participants over time
9-11,13,17,18,33-37
. These human studies evaluate the effects 
of fetal exposures (i.e., due to maternal supplementation), as well as of childhood and adult 
exposures, as measured by proband folate intake or serum folate status. 
 6 
Both folate status and the effect of folate may vary between males and females, as well as 
among racial and ethnic groups. A cross-sectional study based on NHANES data
16
 notes an 
inverse relationship between folate status and wheezing among non-Hispanic white and black 
subjects. Among Hispanic subjects, however, the investigators find an association between 
serum folate and wheezing. Hispanic subjects and non-Hispanic black subjects are noted to have 
significantly lower folate levels. 
NHANES data
38
 also is reported to show higher folate levels among older women as 
compared to men. In a Norwegian study of dietary intake in adolescents with asthma
33
, based on 
food questionnaire data, girls are reported to have a lower dietary intake of folate as compared to 
boys. 
 
3.1 CROSS-SECTIONAL STUDIES 
There are seven cross-sectional studies of folate and asthma or atopy
16-19,33-35
 (summarized in 
Table 1). In the cross-sectional data from the National Health and Nutrition Examination Survey 
(NHANES)
16
, higher serum levels of folate are associated with lower rates of atopy and 
wheezing [for wheezing, adjusted odds ratio (aOR) for highest vs. lowest quintile = 0.6, 95% 
confidence interval (CI) 0.4-0.8]. Atopy is measured with both serum specific and total IgE 
levels. Gestational exposure is not assessed in this study. 
In a case-control study of Egyptian adults
17
, subjects with asthma and positive skin prick 
testing are noted to have significantly lower serum folate levels (9.1 ng/mL vs. 11.3 ng/mL 
among non-atopic asthma patients, p=0.001). In these atopic asthmatic patients, folate levels are 
inversely correlated with serum total IgE. Folate status does not correlate directly with asthma, 
but rather with markers of atopy in atopic asthmatic patients. Another case-control study in 
 7 
England
18
 identifies a direct association between low folate, as measured by food frequency 
questionnaire, and a diagnosis of asthma [aOR for each quintile increase = 0.89, 95% CI 0.81-
0.98]. In a large study of Danish adults, low serum folate is significantly associated with asthma 
diagnosis (aOR for lowest vs. highest quartile = 1.37, 95% CI 1.05-1.79). Despite this evidence 
for an inverse association between folate and asthma, one large Australian study shows evidence 
of a positive association between dietary folate and asthma (OR per microgram = 2.2, 95% CI 
1.2-3.9), and two smaller studies show no evidence for an association between folate status and 
asthma or atopy
33,35
. 
In summary, there is not clear evidence that low levels of folate cause asthma. Several 
observational studies, however, associate low folate status and higher rates of asthma or atopy
16-
19
. This potential protective effect of folate supplementation against asthma or atopy in children 
and adults merits further evaluation. 
 
Table 1. Cross-sectional studies: evidence for association between folate status and asthma or 
atopy 
Evidence for 
association between 
folate status and 
asthma or atopy Reference Summary Limitations 
Inverse association    
 Farres et al.
17
 Study of adults 
(n=180). Among 
subjects with asthma, 
serum folate inversely 
associated with IgE. 
Small sample size and 
lack of dietary intake 
information. 
 Matsui and Matsui
16
 Study of children and 
adults, 2-85 years old 
(n=8,083). Serum 
folate inversely 
associated with 
wheezing.  
Broad age inclusion 
and lack of dietary 
intake information. 
 Patel et al.
18
 Study of adults, 45-75 
years old (n=1,030). 
Dietary folate intake 
inversely associated 
Lack of nutritional 
supplement 
information and lack 
of folate levels. 
8 
with asthma. 
Thuesen et al.
19
 Study of adults, 30-60 
years old (n=6,784). 
Serum folate inversely 
associated with 
asthma. 
Lack of information 
regarding nutritional 
supplements and 
dietary intake. 
Positive association 
Woods et al.
34
 Study of adults, 20-44 
years old (n=1,601). 
Dietary folate intake 
associated with 
asthma. 
Lack of folate levels. 
No association 
Bueso et al.
33
 Study of children, 13-
14 years old (n=169). 
No significant 
association between 
folate intake and 
asthma. 
Small sample size and 
lack of folate levels. 
Shaheen et al.
35
 Study of children, 2-4 
years old (n=40). No 
significant association 
between serum folate 
and atopic dermatitis. 
Small sample size and 
lack of dietary intake 
information. 
3.2 LONGITUDINAL STUDIES 
There are thirteen longitudinal studies of folate and asthma or atopy (summarized in Table 2). 
Only two of these studies are designed to identify associations between a child’s folate status and 
risk of asthma or atopic disease. In one small U.S. cohort, children with higher serum folate 
levels are more likely to have allergic sensitization between 3-9 years of age (rate of sensitization 
to seasonal aeroallergens among high vs. low folate cluster = 21% vs. 44%, p = .03)
15
. In another
small study by the same group, children with second-quartile folate levels have a higher IgE than 
children with first-quartile folate levels (295 vs. 114 kU/L, p <= .01)
39
. These studies are limited
by potential selection bias and small sample size. 
The remainder of these longitudinal studies are birth cohorts in which maternal folate 
status during gestation is assessed in addition to offspring asthma. Such birth cohort studies are 
Table 1 continued
 9 
designed to identify whether folic acid supplementation contributes to increased risk of offspring 
asthma or atopy. Five of these studies use questionnaire data to evaluate maternal folate 
status
9,11-13,37
. In a cohort study from the Netherlands
11
, prenatal folic acid supplementation is 
associated with an increased risk of wheezing in children at age 1 year (prevalence ratio = 1.20, 
95% CI 1.04-1.39). Participants completed yearly questionnaires regarding respiratory disease 
and allergic symptoms. Lab testing at the end of this period included serum specific IgE testing 
as well as a methacholine challenge test. An increased risk of wheeze is observed at age one year 
in the children of mothers who use folic acid supplements during pregnancy, but no other 
associations are noted. In this study, however, maternal folate supplementation and most 
wheezing outcomes are self-reported. 
In a smaller Australian prospective birth cohort
9
, increased folate intake is associated 
with increased risk of physician-diagnosed asthma in offspring at age 3.5 years (RR = 1.26, 95% 
CI 1.08-1.43), as well as with persistent asthma. Significant association is not present on 
reexamination of offspring at age 5.5 years. Self-reported supplementation and food frequency 
questionnaires account for folate intake, and almost one-quarter of the children are not followed 
throughout the study period. Other birth cohorts involving maternal questionnaire data show no 
significant association between folate and asthma
13,37
 or atopy
12
. 
Three birth cohorts reflect the attempt to identify associations between early childhood 
wheezing and maternal folate intake data
8,36,40
. Haberg et al. have conducted multiple studies in 
Norwegian children in which folate supplementation during pregnancy is shown to be associated 
with increased risk of wheezing in early childhood
7,8
. The first study is a large cohort employing 
supplementation data, and the second is a nested case-control study using maternal plasma folate 
data. In their first study
8
 [adjusted relative risk (aRR) for offspring wheezing = 1.06, 95% CI 
 10 
1.03-1.10], the maternal folate supplementation is self-reported, and in both studies the wheezing 
outcomes is primarily self-reported. In the later study (aOR for offspring asthma at age 3 years 
for highest vs. lowest quintile = 1.66, 95% CI 1.16-2.37)
7
, wheezing is assessed both by positive 
response to a maternal questionnaire, and by the use of asthma therapy within the preceding year. 
The investigators also find a correlation between reported maternal folate supplementation and 
maternal serum folate levels. Two other studies of early childhood wheezing involving maternal 
folate intake data
36,40
 show no effect of maternal folate on asthma. 
Three of the birth cohorts, including the nested Haberg study
7
, evaluate maternal serum 
or red blood cell folate measurements
10,14
. In a Netherlands cohort study
10
, higher levels of 
maternal folate are associated with a slightly decreased risk of asthma (i.e., an inverse 
relationship) in children age 7 to 8 years (p-value for trend across quintiles = .05). In this study, 
however, more than a quarter of the children are not followed up to age 7, and less than a third of 
the mothers have laboratory folate measurements. While a Dutch cohort shows no evidence of 
association between maternal folate and asthma, there is a significant positive association 
between first-trimester maternal serum folate and offspring eczema (aOR = 1.18, 95% CI 1.05-
1.33)
14
. 
Among these birth cohorts, there are differences not only in measurement of folate status, 
whether self-reported or assessed in a laboratory, but also in the characterization of wheezing. 
Self-reported outcomes, in which parents note that their children wheeze, for example, are used 
in most of the studies
7,8,11,36,40
, but physician-diagnosed asthma is employed frequently as 
well
9,10,13,37
. Birth cohorts evaluating maternal supplementation and early childhood (under age 
5) asthma or atopy include some evidence of positive association
7-9,14
 or no effect
36,40
. Such 
studies, however, are limited both by short duration of follow-up as well as by the difficulty of 
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identifying asthma phenotypes in early childhood
32
. On the other hand, the birth cohorts 
involving asthma or atopy among older children—and its association with maternal folate 
questionnaire data
9,11-13,37—are limited by substantial loss to follow-up (up to 62%)32. While 
many studies of folate incorporate pulmonary function data
10,19,39
, including some with 
methacholine challenge, there are no significant objective findings. 
In summary, five of the birth cohort studies show no evidence for association between 
maternal folate status  during gestation and offspring asthma or atopy. Nevertheless, five birth 
cohorts
7-9,11,14
, including the largest such study to date
8
, offer weak evidence of a positive 
association between maternal folate status and offspring asthma or atopy. The effect of 
gestational supplementation warrants further consideration in large, well-designed observational 
studies.  
 
Table 2. Longitudinal studies: evidence for association between folate status and asthma or 
atopy 
Evidence for 
association between 
folate status and 
asthma or atopy Reference Summary Limitations 
Inverse association    
 Magdelijns et al.
10
 Study of mothers and 
children, up to 7 years 
old (n=2,834). 
Maternal intracellular 
folate inversely 
associated with 
offspring asthma.  
Lack of information 
regarding maternal 
dietary intake. 
Positive association    
 Bekkers et al.
11
 Study of mothers and 
children, up to 8 years 
old (n=3,786). 
Maternal folate 
supplementation 
associated with 
offspring wheezing. 
Lack of information 
regarding maternal 
dietary intake or folate 
levels. 
 Haberg et al.
8
 Study of mothers and 
children, up to 18 
months old 
Lack of folate levels 
and limited 
discrimination 
12 
(n=32,077). First-
trimester maternal 
supplementation 
associated with 
offspring asthma. 
between early 
childhood wheezing 
and asthma. 
Haberg et al.
7
 Study of mothers and 
children, up to 3 years 
old (n=1,962). 
Second-trimester 
maternal serum folate 
associated with 
offspring wheezing. 
Lack of information 
regarding dietary 
intake and limited 
discrimination 
between early 
childhood wheezing 
and asthma. 
Kiefte-de Jong et al.
14
 Study of mothers and 
children, up to 4 years 
old (n=8,742). First-
trimester maternal 
serum folate 
associated with 
offspring atopic 
dermatitis. 
Limited 
discrimination 
between early 
childhood wheezing 
and asthma. 
Lin et al.
39
 Study of children, 5-
17 years old (n=144). 
Compared to first 
quartile, second 
quartile serum folate 
associated with IgE. 
Small sample size and 
lack of information 
regarding dietary 
intake.  
Okupa et al.
15
 Study of children, 2-9 
years old (n=138). 
Serum folate levels 
associated with 
allergic sensitization. 
Small sample size and 
lack of information 
regarding dietary 
intake. 
Whitrow et al.
9
 Study of mothers and 
children, up to 5.5 
years old (n=423). 
Maternal folate 
supplementation 
associated with 
offspring asthma. 
Lack of folate levels. 
No association 
Granell et al.
12
 Study of mothers and 
children, up to 7-8 
years old (n=5,364). 
No significant 
association between 
third-trimester 
maternal 
supplementation and 
offspring atopy. 
Limited information 
regarding maternal 
dietary intake and lack 
of folate levels. 
Litonjua et al.
40
 Study of mothers and 
children, up to 2 years 
old (n=1,290). No 
Lack of information 
regarding maternal 
folate levels and 
Table 2 Continued 
13 
significant association 
between first- or 
second-trimester 
maternal folate intake 
and offspring 
wheezing.   
limited discrimination 
between early 
childhood wheezing 
and asthma. 
Martinussen et al.
37
 Study of mothers and 
children, up to 6 years 
old (n=1,499). No 
significant association 
between first-trimester 
maternal folate 
supplementation and 
offspring asthma. 
Limited information 
regarding maternal 
dietary intake and lack 
of folate levels.  
Miyake et al.
36
 Study of mothers and 
children, up to 24 
months old (n=763). 
No significant 
association between 
maternal folate intake 
and offspring 
wheezing. 
Limited information 
regarding maternal 
dietary intake and lack 
of folate levels, as 
well as limited 
discrimination 
between early 
childhood wheezing 
and asthma. 
Nwaru et al.
13
 Study of mothers and 
children, up to 5 years 
old (n=2,441). No 
significant association 
between third-
trimester maternal 
folate intake and 
offspring asthma. 
Limited information 
regarding maternal 
dietary intake and lack 
of folate levels. 
4.0 FOLATE MEASUREMENT 
Low serum folate is typically identified as less than 3 ng/mL
38
. Red blood cell folate (normal
>140ng/mL) is understood to reflect levels of stored folates
41
. In the U.S., patterns of folate
deficiency changed dramatically after the mandatory folic acid food fortification program was 
instituted from 1996-1998. This program was undertaken to reduce the risk of neural tube defects 
(NTD), and NTD incidence dropped significantly following folic acid fortification
42
. The United
States National Health and Nutrition Examination Survey (NHANES) data from 2010 indicates 
Table 2 Continued 
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that the prevalence of low serum folate decreased from 24% to <=1% since fortification
43
. In 
countries where fortification is inadequate, NTD rates can remain unchanged
44
. 
There is substantial variability among the asthma and atopy studies discussed above  as to 
when and how folate is measured. As noted, many of the studies use maternal self-reported folate 
supplementation and food frequency questionnaires
8,9,11,13,37,40
, with no laboratory measurement 
of folate. Moreover, in one study
36
, supplement use is ignored. Among studies that involve 
laboratory measurement, some use serum folate values
7
 and others use intracellular folate 
levels
10
, which can more accurately reflect folic acid stores over preceding months
41
. 
Folate measurements are variably effective in different subjects. If 5-methyl-THF 
predominates as the one-carbon form of folate in serum and red blood cells, conventional assays 
can be sufficient. On the other hand, in people with the common MTHFR C677T polymorphism, 
for example, a variety of other one-carbon folate forms are present
45
 that may go underestimated. 
Other approaches, including mass spectrometry, can more effectively assess the presence of both 
folate metabolites and unmetabolized folic acid
46
. 
These studies come to varied conclusions regarding the timing of maternal folate 
supplementation. Haberg et al. note increased wheezing in children born to mothers who 
supplement folate in the first trimester
8
 and in the second trimester
7
. Whitrow et al. note a similar 
association in children born to mothers who supplement folate in the third trimester
9
, but not in 
early pregnancy. These authors suggest that a second trimester effect of maternal folate on 
asthma could be mediated by the increase in amniotic IgE characteristic of gestation weeks 16-
18
47
. This positive association is not noted consistently, however. The Martinussen et al.
37
 
prospective cohort study, for example, is designed to evaluate the effect of first-trimester folate 
supplementation, and no increased wheezing in offspring is observed. 
 15 
Folate intake can be difficult to assess with food frequency questionnaires
19
. Folates in 
foods have poor stability and incomplete bioavailability
48
. By comparison, folic acid 
supplementation is relatively stable and bioavailable. Food frequency questionnaires have been 
specially modified for use in pregnancy methyl-donor studies
49
. 
In Bueso et al.
33
, participants complete a four-day food diary. They are given a video with 
instructions regarding how to fill out the 18-page form. An accompanying photographic booklet 
helps these teenage participants to identify portion size. A similar food frequency questionnaire, 
validated for use in a Japanese population, is used in the Miyake et al.
36
 prospective study. 
Validated food frequency questionnaires are also employed in Whitrow et al.
9
, but multiple 
commentators suggest that these estimates are incorrect
50,51
 because they take into account only 
free folic acid and do not include accurate fortification data. 
Multiple quality cohort studies
8,11,16,37
 focus only on the presence of supplements and do 
not account for maternal dietary intake. High serum folate levels are commonly associated with 
supplement use
52
, and it is reasonable to question the relevance of enriched cereal-grain product 
consumption in studies of adverse folate effects. Nevertheless, the complexity of evaluating food 
diaries and questionnaires, as well as measuring folate in the laboratory, provides one indication 
of why consistent findings in studies of folate and asthma are difficult to achieve. 
A causative pattern of folate supplementation triggering offspring wheezing may not stop 
at birth. This positive relationship could persist through a critical period of early childhood 
during which high folate levels would continue to be associated with allergic sensitization
15
. In 
later childhood, however, folate could change from a causative factor in childhood wheezing to a 
protective one. 
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5.0 FOLATE GENE-BY-ENVIRONMENT INTERACTIONS 
The methylenetetrahydrofoate reductase (MTHFR) gene is frequently implicated in studies of 
folate status and asthma. The common homozygous C677T mutation in the MTHFR gene is 
reported as a cause of abnormal folate metabolism
45
. The T allele has an allele frequency of more 
than one-third in multiple reports
30,53
. Individuals with the TT genotype have consistently lower 
serum folate than other genotypes, and some authors suggest that this genotype can be used as a 
marker of low folate status
19
. 
In a large English cohort study including 5,364 children
12
, atopy is assessed in children 
ages 7 to 8 by skin prick testing, and the children are assessed for the presence of physician-
diagnosed asthma or current symptoms. The MTHFR C677T variant is not noted to have an 
association with asthma or allergy in these children, even after adjustment for dietary folate 
intake. 
Likewise, a cross-sectional study of Danish adolescents and adults
20
 does not find an 
association between the C677T polymorphism and either subjective or objective indicators of 
atopy. Lab data from this study includes serum specific IgE, skin prick testing, and methacholine 
challenge. In a subsequent cross-sectional study with longitudinal follow-up by the same 
authors
19
, however, there is an association between  doctor-diagnosed asthma and both folate 
status and C677T polymorphism (TT vs. CC genotype aOR = 1.52, 95% CI 1.12-2.06). They 
also note that individuals with both TT genotype and low estimated dietary folate intake are even 
more likely to have atopy when compared with those with higher folate intake. A Chinese case-
control study of 1,682 adults likewise finds greater prevalence of the TT genotype among atopic 
asthmatic patients as compared with controls
54
. 
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In a separate cross-sectional study of 1,482 Danish adults
21
, Husemoen et al. identify the 
MTHFR C677T variant genotype and assess serum specific IgE levels for inhalant allergens. The 
MTHFR TT homozygotes have a significantly higher risk for atopy than either heterozygotes 
(CT) or normal (CC) individuals (aOR 1.76, 95% CI 1.19-2.60). This study does not assess the 
presence of asthma, however. 
A cohort study of Spanish children at ages 4 to 6 years
55
 identifies hypomethylation of 
the arachidonate 12-lipoxygenase (ALOX12) gene as being associated with increased risk of 
persistent wheezing. The investigators collect data regarding maternal folate supplementation 
during pregnancy, but no association between gestational folate supplementation and ALOX12 
hypomethylation is identified. 
While there is a possible association between folate and asthma, there is not a genetic 
marker of folate status that consistently is associated with asthma or atopy. There is good 
evidence for association between MTHFR genotype and folate status
19
, but the interpretation of 
MTHFR asthma studies is limited due to possible selection bias, as well as insufficient 
identification of the asthma phenotype
32
. Individuals with genetic polymorphisms may have a 
different distribution of folate metabolites
46
, and a complete laboratory folate evaluation could 
yield more consistent results. 
 
6.0 MECHANISMS OF FOLATE EFFECTS ON ASTHMA OR ATOPY 
The primary mechanistic explanation for folate effects in asthma or atopy is DNA methylation. 
Epigenetic change could also account for heritable disease risk. Synergistic effects associated 
with varied diets high in fruits and vegetables
56
, however, could also account for the perceived 
effects of folate status. 
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6.1 MATERNAL SUPPLEMENTATION AND METHYLATION 
Methylation patterns can affect genetic expression broadly, but they are also implicated in 
specific patterns of cytokine production in the asthma phenotype
57
. T lymphocytes mature into 
Th1 and Th2 lineages that generate cellular or humoral immune response. Th2 cells, which are 
associated with distinct methylation patterns
58
, produce cytokines implicated in asthma and other 
atopic response. 
At the 5’ end of a gene, there is a higher prevalence of cytidine phosphate guanosine 
(CpG) sequences, called CpG islands
59
. Methylation of CpG islands in promoter regions can 
silence transcription
60
. Approximately 88% of active promoter regions are associated with CpG 
islands and can thereby theoretically be governed by methylation
61
. FoxP3 is a transcription 
factor regulating development of Treg cells, which modulate the immune response. FoxP3 
expression and Treg cell development are noted to vary with methylation patterns
62
. 
DNA methylation has an epigenetic role in the development of a Th2 phenotype
5,63
. 
Folate, like dietary methionine and choline, is identified as a methyl donor that leads to the 
methylation of DNA
64
. A methyl donor can alter disease risk by methylating, and thereby 
downregulating, genes that govern the development of an atopic phenotype. Prescott and 
Clifton
63
 identify folate as being the current most notable candidate for epigenetic determination 
of asthma phenotype. The Runx3 transcription factor implicated in the Hollingsworth study has a 
corresponding binding site in the FoxP3 promoter region, and Runx3 and FoxP3 are identified 
jointly as important to the development of the Treg lineage
65
. 
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6.2 FOLATE STATUS AND IMMUNE SYSTEM FUNCTION 
Folate is suggested to modulate immune response and provide resistance to infection. Folate 
deficiency decreases numbers of circulating T lymphocytes
66
 and impairs natural killer (NK) 
cell-mediated cytotoxicity
67
. A mother who continues to take supplements after the birth of her 
child could be less likely to develop respiratory illness herself, and therefore less likely to have 
children who wheeze
40
. 
Folate status can also be a marker of nutritional status
15
. Many vitamins and trace 
elements are studied for their effect on immune function. Children with low folate could have 
multiple relative nutritional deficiencies that cumulatively would put them at risk for wheezing 
illness. The cross-sectional Australian study of 1,601 young adults
34
 finds that apple and pear 
consumption are protective for asthma (aOR 0.83, 95% CI 0.71-0.98), and people consuming 
fewer dietary antioxidants are noted to have increased bronchial reactivity
68
. 
 
6.3 FOLATE TOXICITY AND IMMUNE REGULATION 
The synthetic folic acid found in supplements is absorbed differently than dietary folates, and 
intestinal folic acid transport is saturable
69
. Excess intake can result in circulating unmetabolized 
folic acid
70
. The effects of unmetabolized folic acid are unknown, but some investigators have 
proposed that the circulating folic acid can cause immune dysregulation, including reduced 
natural killer cell cytotoxicity
71
. 
 
7.0 SUMMARY AND FUTURE DIRECTIONS 
Several studies of maternal folate supplementation find an association with increased risk of 
wheezing, asthma, or other markers of atopy in offspring
7-9,11
. The murine model study suggests 
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the same association, and even identifies reversibility of DNA methylation in atopy candidate 
genes
6
. Differential methylation is the most promising mechanism to explain the effect of folate 
on the development of asthma. 
Higher serum levels of folate in a patient at risk for asthma or atopy may be protective
16-
19
, but studies of low folate status in patients with MTHFR polymorphism have shown varied 
results
12,21
. Approaches to the assessment of folate status vary widely, and there are multiple 
challenges that complicate the accurate recording of dietary folate intake. 
Most of these conclusions are drawn from observational studies. There is established 
benefit of maternal folate supplementation in preventing NTD, and changes to folate intake 
cannot be recommended on the basis of available literature. There are not randomized clinical 
trials investigating the effects of differing levels of folate supplementation
72
. Moreover, effective 
accounting for folate levels will entail joint study of intake, supplementation, and serum levels. 
The value of employing red blood cell folate in these studies is not yet known, and serum 
measurements should include multiple folate species (e.g., 5-methyl-THF, 5-formyl-THF, and 
folic acid) that comprise total folate in serum
73
. 
 
7.1 PUBLIC HEALTH RECOMMENDATIONS 
Several studies suggest a protective effect of folate in children and adults that is the opposite of 
gestational exposure, and effects on all these groups warrant further investigation. Large 
observational studies would be needed prior to the launch of clinical trials assessing safety, 
dosing, and delivery of folate in asthma treatment. In addition, recommendations could vary 
based on timing, sex, race, and ethnicity, and these factors will need to be explored in future 
studies. 
 21 
In evaluating the impact of the murine model study, Miller
74
 speculates about a 
connection between folate supplementation and increasing asthma prevalence, but cautions 
against drawing conclusions from an animal model. Moreover, the primary increase in asthma 
prevalence in the United States occurred prior to the mandatory folic acid supplementation of 
foods
75
. 
Some investigators suggest that there could be an optimal time for folic acid 
supplementation, in which neuroprotective effects are maintained but atopy risks are 
minimized
14,76
. The decision-making process governing folate supplementation could differ 
depending on the patient population
50
. In populations at lower risk for asthma, for example, 
maternal folate supplementation could be even more strongly encouraged in order to limit risks 
of spina bifida and pregnancy-associated anemia. 
Ultimately, public health recommendations directed toward asthma—or any other 
perceived supplementation risk—will depend on our thorough understanding of how folate 
reduces NTD. Some women who take folic acid still have offspring with NTD, which has 
prompted a search for other nutritional or genetic factors underlying NTD
77
. The delineation of 
the dose-response relationship between folate and NTD will be needed to guide future public 
health recommendations
72
 for other disease processes such as asthma. 
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